Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gerson

Showing results (201-210 of 257) with videos related to

Pageof 26
Sort By:
Journal of Virology|January 18, 2008
Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replicationYong Gao, Michael A Lobritz, Justin Roth, et al.
British Journal of Haematology|December 24, 2005
Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment deviceWillem J van Heeckeren, Jennifer Vollweiler, Pingfu Fu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Inhibition of 15-PGDH Protects Mice from Immune-Mediated Bone Marrow FailureJulianne N P Smith, Folashade Otegbeye, Alvin P Jogasuria, et al.
British Journal of Haematology|August 7, 2009
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaPaul M Barr, Pingfu Fu, Hillard M Lazarus, et al.
Cancer Research|June 4, 2008
Identification of 6-benzylthioinosine as a myeloid leukemia differentiation-inducing compoundDavid N Wald, Hanna M Vermaat, Shaolei Zang, et al.
JAMA Dermatology|February 16, 2017
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical TrialJoselin D Tacastacas, Derek V Chan, Sean Carlson, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung CancerNooshin Hashemi Sadraei, Yan Feng, Lingling Du, et al.
Bone Marrow Transplantation|March 14, 2000
CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcomeH M Lazarus, A L Pecora, T C Shea, et al.
Oncotarget|November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignanciesPaolo F Caimi, Brenda W Cooper, Basem M William, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2019
Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple MyelomaRebecca Ye, Sirisha Kundrapu, Stanton L Gerson, et al.
Pageof 26

Showing results (201-210 of 257) with videos related to

Sort By:
Pageof 26
Journal of Virology|January 18, 2008
Targets of small interfering RNA restriction during human immunodeficiency virus type 1 replicationYong Gao, Michael A Lobritz, Justin Roth, et al.
British Journal of Haematology|December 24, 2005
Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment deviceWillem J van Heeckeren, Jennifer Vollweiler, Pingfu Fu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Inhibition of 15-PGDH Protects Mice from Immune-Mediated Bone Marrow FailureJulianne N P Smith, Folashade Otegbeye, Alvin P Jogasuria, et al.
British Journal of Haematology|August 7, 2009
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphomaPaul M Barr, Pingfu Fu, Hillard M Lazarus, et al.
Cancer Research|June 4, 2008
Identification of 6-benzylthioinosine as a myeloid leukemia differentiation-inducing compoundDavid N Wald, Hanna M Vermaat, Shaolei Zang, et al.
JAMA Dermatology|February 16, 2017
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical TrialJoselin D Tacastacas, Derek V Chan, Sean Carlson, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung CancerNooshin Hashemi Sadraei, Yan Feng, Lingling Du, et al.
Bone Marrow Transplantation|March 14, 2000
CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4 degrees C does not affect outcomeH M Lazarus, A L Pecora, T C Shea, et al.
Oncotarget|November 8, 2017
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignanciesPaolo F Caimi, Brenda W Cooper, Basem M William, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2019
Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple MyelomaRebecca Ye, Sirisha Kundrapu, Stanton L Gerson, et al.
Pageof 26